chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Temperature excursion, vaccine was exposed to temp as high as 55 degrees F unmixed for a 6 hour period prior to getting vaccine; Temperature excursion, vaccine wasexposed to temp as high as 55 degrees F unmixed for a 6 hour period prior to getting vaccine; This is a spontaneous report from a contactable nurse. A 23-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM9810) via an intramuscular route of administration in the left arm on 24Feb2021 at 07:00 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 24Feb2021 at 07:00, the patient experienced temperature excursion where vaccine was exposed to temp as high as 55 degrees F which was unmixed for a 6 hours period prior to vaccination. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the event temperature excursion where vaccine was exposed to temp as high as 55 degrees F which was unmixed for a 6 hours period prior to vaccination was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
This spontaneous report was received from a pharmacist refers to a patient of unknown age and gender. The patient's concomitant medications, pertinent medical history, drug reactions or allergies were not reported. In November 2017, the patient was vaccinated with first dose of GARDASIL 9 (lot #, expiration date, dose, strength and route of administration were not provided) for prophylaxis. On 07-AUG-2018, the patient was vaccinated with the second dose of GARDASIL 9 (lot # R010596, expiration date 11-DEC-2020) (dose, strength and route of administration were not provided) for prophylaxis. No adverse effect was reported.
One day post vax, this pt experienced low grade fever, diarrhea and a stomach virus. Follow up information from pharmacist indicated that events related to stomach virus that was "going around the family."
Information has been received from a registered nurse, for HPV vaccine, a Pregnancy Registered product, concerning a 21 year old female patient with allergic to CECLOR and with a history of seizures who was vaccinated IM with the first 0.5ml dose and the second dose of HPV vaccine (lot# 671463/1359AA) on 19-JAN-2012 and 16-MAR-2012, respectively. Concomitant therapy included KEPPRA, LAMICTAL and folic acid. Nurse reported that on 07-FEB-2012, the patient was seen at the obstetrics (OB) office, and it was determined that the patient was 9 weeks pregnant. Nurse reported that the patient received the second dose of HPV vaccine on 16-MAR-2012, while the patient was 14 weeks pregnant. Last menstrual period (LMP) was approximately on 06-DEC-2011 and estimated delivery date (EDD) was on 11-SEP-2012. Nurse reported that the patient was not experiencing any adverse effects. Nurse reported that the patient received the HPV vaccine at the patient's primary care office, not the OB office. Prenatal care was given for the event. Lab diagnostics studies performed included blood work (results unspecified). The patient sought unspecified medical attention. Follow up information has been received from the registered nurse concerning a 21 year female with allergic to CECLOR and with epilepsy and obesity and with a history of seizures who was vaccinated IM with the first 0.5ml dose and the second dose of HPV vaccine (lot# of dose 1: 668261/1397AA; lot# of dose 2: 671463/1359AA) on 19-JAN-2012 and 16-MAR-2012, respectively. Last menstrual period (LMP) was approximately on 09-JAN-2012 and estimated delivery date (EDD) was on 15-OCT-2012. The patient was placed on PNV for pregnancy. The patient had 2 previous pregnancies. The number of full term deliveries was one. There were no infant complications in previous pregnancies and no birth defect in previous pregnancy. Follow-up information has been received and reported that all telephone attempts to obtain follow-up information have been unsuccessful. Additional information is not expected.
hospitalized 10/6 - fully vaccinated for COVID19, has yet to get booster, with PMH of HTN, HLD who presented to the ED with complaints of SOA. Pt reports that he started feeling poorly 4 days PTA on 10/2/21 with congestion, dry cough, low grade fever and fatigue. He went to the pharmacy for a rapid COVID test and was diagnosed on 10/3/21.  He reports that he has since been monitoring his O2 and his O2 was 88% today, so he came in for evaluation.
Seizure event possibly longer than 15 minutes. Mother found her slumped over in bed with foaming at the mouth. +postictal state. She did have a fever
Fatigue; arm pain at site of injection; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 25-year-old female patient (not pregnant) received meningococcal group b Rlp2086 (TRUMENBA), on 23Mar2023 at 01:30 as dose 3, single (Batch/Lot number: unknown) at the age of 25 years, in arm for immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: FATIGUE (non-serious) with onset 23Mar2023 at 16:45, outcome "recovered" (25Mar2023); INJECTION SITE PAIN (non-serious) with onset 23Mar2023 at 16:45, outcome "recovered" (25Mar2023), described as "arm pain at site of injection". Therapeutic measures were not taken as a result of fatigue, injection site pain.  The information on the batch/lot number for meningococcal group b Rlp2086 has been requested and will be submitted if and when received.
Severe body aches; hurt all over, especially joints Pain at injection Red and warm to touch at injection site Nausea Severe headache Fatigue
get the shot and he got shingles/suspected vaccination failure; shingles/get the shot and he got shingles; still has the pain from them; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles and pain were not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.     Additional Information: GSK receipt date: 21-Sept-2022 Reporter's comment: The case was received from the patient's wife via interactive digital media. The patient never had chickenpox. The patient's physician told him to get the shot and guess what he got shingles, has had them for over a year still has had the pain from them. The reporter stated that they were told that the patient should not have the shingles shot. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Pt had fever and seizure at 04:00 on 8/22/00 and another seizure at 12:00. She was placed on diazepam and no more seizures. Temperature was 103.7F in office. Seizure lasted a minute. On 11/6/00, had another seizure at school and temperature was 100.7F on arrival at ER.
chief complaint of shortness of breath and difficulty breathing that began this afternoon he was at a routine office visit this morning when he was found to be hypoxic and tachypneic - treated with IV abx x5 days for CAP
Just slightly sore right arm; "Administration date 06Oct2021, dose number=3"; This is a spontaneous report from a contactable consumer, the patient. A 74-year-old non-pregnant female patient received the third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF2589) via an unspecified route of administration in the right arm on 06Oct2021 at 11:00, (at the age of 74-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic obstructive pulmonary disease (COPD) and breast cancer. The patient was allergic to sulfuric drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received other vaccine within four weeks prior to the vaccination which included influenza vaccine (MANUFACTURER UNKNOWN) on 03Oct2021 in the left arm for an unknown indication and unknown if ongoing. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), simvastatin (MANUFACTURER UNKNOWN), fluticasone (MANUFACTURER UNKNOWN) and fluticasone propionate, salmeterol xinafoate (ADVAIR); all from unknown dates for unknown indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 09Mar2021 at 14:00 (at the age of 73-years-old) as a single dose for COVID-19 immunisation and also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 30Mar2021 at 14:15 (at the age of 73-years-old) as a single dose for COVID-19 immunisation. On 06Oct2021 at 11:00, the patient experienced "administration date 06Oct2021, dose number=3". On 07Oct2021 at 08:00, the patient had just slightly sore right arm. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of event reported. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event just slightly sore right arm was resolved on an unknown date in Oct2021. The clinical outcome of the event "administration date 06Oct2021, dose number=3" was unknown.
Swelling of face, thoat tightness, SOB. Generalized itching, hives, dizziness. Hypotension within 10 minutes of the allergic reaction.
Arm below injection site is heavy, sore, bright red, hot to touch and slightly swollen.  A bit itchy
Had vomiting a day after TRUMENBA vaccine (but reports also has vomiting when she does not take Doxycyline with food, however the vomiting she had the after the vaccine was not related to Doxycyline). Also had decrease in appetite (was skipping meals and eating less) and increase in headache frequency. Headaches were improving when I saw her.
Pt experienced a very high fever of 102 for about 24 hours that began within 8 hours post vax. Pt also developed a rash all over torso and expe5rienced lethargy. Pt was seen by physician who eliminated the possibility of chicken pox. No treatment was prescribed.
Patient received H1N1 vaccine IM 10/23/2009, 2 days later she had chest pressure and congestion. She had chest pains with cough 10/31/09. She saw her physician 11/6 and went to urgent care and then ER. CXR was negative. CT appeared negative. ECHO and EK no clinical. History of chest pain persisted till 11/8.  11/25/09 Medical records received for DOS  11/03- 11/08. Final DX; Chest pain C/O chest pain, radiates to L arm, needs deep breath. Burning pain.  Recurrent. Increasing frequency. Nausea, abd pain, constipation.   10 min episodes. Numbness hands/feet.  EKG WNL. Resolved.    ICD9 Codes: 785.50A
Normal, reported symptoms appeared 12/30/2020 approximately 7 hours after injection. Symptoms included fatigue lasting 1-2 days after injection, and swelling, redness, soreness and fever around the injection site on the right arm. All above symptoms disappeared by 1/2/2021. However, the symptoms on the injection site (arm redness, swelling, soreness and fever around injection site) reappeared on 1/9/2020 and are current. Symptoms are mild in nature.
Had vaccination last year and I have a mild case of shingles/ suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, less than 2 years after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Had vaccination last year and I have a mild case of shingles/ suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 13-JUN-2023 This case was reported by a patient via interactive digital media. The patient reported that because you receive vaccination does not mean that you will still experience shingles. The patient stated that he or she received Shingles vaccine last year and still have mild case of Shingles right now. This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
Resident  received Janssen Covid 19 vaccination on 5/25.  On 5/29, the resident died.
FEELING LIGHT HEADED. RED EYE. STARTED TO SWEAT. CHECKED HER BLOOD PRESSURE THREE TIMES. SHE STATED SHE HAD NOT EATEN AND DID NOT TAKE HER BLOOD PRESSURE MEDICATIONS. 1ST BP. 180/30, 2ND. 211/181 3RD/ 241 /111 PULSE 66/
Achy from head to toe on both side of the body; Headache; Fever; Fatigue; Sore Left Arm; Achy on the left side of body; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore Left Arm), PAIN (Achy on the left side of body), PAIN (Achy from head to toe on both side of the body), HEADACHE (Headache) and PYREXIA (Fever) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Low blood pressure.   On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore Left Arm), PAIN (Achy on the left side of body), PYREXIA (Fever) and FATIGUE (Fatigue). On 25-Mar-2021, the patient experienced PAIN (Achy from head to toe on both side of the body) and HEADACHE (Headache). On 13-Mar-2021, PAIN IN EXTREMITY (Sore Left Arm), PAIN (Achy on the left side of body) and FATIGUE (Fatigue) had resolved. On 24-Mar-2021, PYREXIA (Fever) outcome was unknown. At the time of the report, PAIN (Achy from head to toe on both side of the body) and HEADACHE (Headache) outcome was unknown. Not Provided          No relevant concomitant medications were reported. No treatment information was provided.
Pt had series of Engerix-B vaccinations; Did not respond to first 3 shots. P/given the 4th & 5th shots experienced visual disturbances described as "cob webs or floaters."  Eye MD said not serious. 05NOV90-floaters have dec; flashers unchng
Mom noticed at 5:30 pm on 2/20/18 3 inches of redness around left deltoid and was given BENADRYL. When patient awoke on 2/21/18 there was 5 inches, redness, warm to touch and pain with motion.
Patient presented to pharmacy on 10/27/22 with rash/sores on torso.  She complained of persistent itch and stated the issue began the day after shingrix vaccination (8/16/22).  Patient was advised to consider otc oral benadryl and topical antibiotic ointment.  Additionally, it was recommended that she not receive the second dose of shingrix and to follow up with PCP if no improvement.
A weird lump in her throat; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL DISCOMFORT (A weird lump in her throat) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced OROPHARYNGEAL DISCOMFORT (A weird lump in her throat). On 12-Mar-2021, OROPHARYNGEAL DISCOMFORT (A weird lump in her throat) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.
Inappropriate schedule of vaccine/cannot confirm that she ever received her 2nd dose of Shingrix; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose in July 2018 probably in her left arm ).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: Inappropriate schedule of vaccine/cannot confirm that she ever received her 2nd dose of Shingrix). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 26-Jul-2023 The reporter was reported that she received her 1st dose of Shingrix in July 2018 probably in her left arm (no further information provided about this vaccine), and cannot confirm that she ever received her 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter was not ask for consent to follow up with HCP.
rt cheek w/inc swelling @ 1055PM till 11AM; bilat cheeks red when crying &laying head on dad's shoulder; Epi given, HR 115, resp rhythmical & even;
This spontaneous report was received from a health care worker referring to a patient of unknown age and gender. On 06-OCT-2014 the patient was vaccinated with PNEUMOVAX 23 (Lot# unspecified), injection, strength was reported as 25/0.5 Y (dose, frequency and route unspecified). The product expired on 16-JUL-2014. No adverse effects were reported. Additional information is not expected.
I got the shingles shot and had a few on my right side/ Suspected vaccination failure; I got the shingles shot and had a few on my right side; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was recovered/resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. The patient received Shingles vaccine and had a few shingles on his/her right side. The patient stated that he/she did not had any pain and they were gone in a few days. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting. The follow-up would not possible as no contact details were available.
45 min after vaccination felt cognitively dissociated "drunk/high", giggling, speech slurred, motor function compromised lasting about 90 min then slept 2 hrs then woke up felt clearer in head but with headache, arm soreness, tired.  Next day lethargy and pain resolved.  Decreased cognitive clarity lasted throughout the next day to the point patient made several errors at work.
Symptoms - ? at approximately 18:00 began with body aches, chills and febrile.  EE reports Tmax 101.  + sore throat.  EE denies COVID-19 exposure without PPE and denies recent travel.  EE reports she is pregnant at this time. Last day of work and shift - ? yesterday Home remedies? -   1,000 mg of Tylenol at 08:00 Any improvement? ? mild improvement Recommendation?  After completely algorithm, EE meets criteria to be COVID tested and removed from work at this time.  EE provided with EH command center and instructions to notify them need for COVID-19 testing.  EE educated to notify his manager.  EE verbalized back understanding and denied further questions at this time.
Fine pink, blanching macular and papular rash most prominent over collar area, cheeks and groin relatively sparing the extremities.
Initial complaint was lymph node swelling and rash on right side of neck.   Mentioned symptoms to acupuncturist who provided treatment for 4 weeks; no resolution. Showed symptoms to chiropractor who recommended heavy metal detox. Primary provider (listed on previous page) dismissed reaction. Did heavy metal foot soak with chiropractor. Drainage coming from eyes - felt like "acid" or "chemical burn" at tear ducts and above eyes. Treated for pinkeye with PCP; no resolution. Referred to eye doctor Dr. Treated with lotemax. Treatment ongoing, now improving. Turned to "alternative medications." quiercetin 500 mg, liposomal glutathione (antioxidant), multivitamin, zinc, magnesium, vitamin C, Mac 600 and Toxin Pul. Rash is now completely gone and lump/swollen lymph node also resolved. Current symptoms include fatigue and "brain fog."
I started feeling like I was coming down with a cold around December 27th, I was congested and a slight cough. I started taking ALKA-SELTZER PLUS. On the 29th I was still feeling poorly, so I decided to test for COVID-19 and it showed up as positive. I called my PCP's office to let them know and she sent over a prescription to the pharmacy for a Z-PAK. I started taking it that day and the next 4 days. Overall just felt like I was sick, a slight dry cough but mostly just congestion, never any fever. I continued taking THE ALKA-SELTZER, and supplements, and tea. I tested again on January 3rd and was still positive. I tested again on the 7th and was finally negative. The only residual symptom is a dry cough.